Eisai Clinical Trials
Study Overview
E2086
ledasorexton
NCT07493265, 2025-523503-30
Mar 2026 - Mar 2027
Narcolepsy Type 1
1. Change from Baseline to Week 4 in MSL for E2086 Compared With Placebo Across Four MWTs in Participants With NT1 and NT2 [Time Frame: Baseline and Week 4]
-
Males and females 18 Years and older (Adult, Older Adult)
-
Not started -
Phase 2
Belgium, Canada, China, Germany, Italy, Japan, Korea, Republic of, Spain, United States See moreData Sharing
ClinicalStudyDataRequest.com (CSDR) is a multi sponsor site through which qualified researchers who wish to access clinical trial data and associated information in order to conduct further research can submit their research proposal or enquiry.
CSDR Sharing is not available for this study.
CSDR Availability Clinical Trial Data Redacted documents may be available upon request for this study.
Document type Availability Protocol SAP Sample CRF Full CSR